These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 32500804)
1. Clinical validation of the self-reported Glasgow Antipsychotic Side-effect Scale using the clinician-rated UKU side-effect scale as gold standard reference. Schouby Bock M; Nørgaard Van Achter O; Dines D; Simonsen Speed M; Correll CU; Mors O; Østergaard SD; Kølbæk P J Psychopharmacol; 2020 Aug; 34(8):820-828. PubMed ID: 32500804 [TBL] [Abstract][Full Text] [Related]
2. Reliability and Validity of the Short Version of Udvalg for Kliniske Undersogelser in Antipsychotic Treatment. Chen KP; Lung FW Psychiatr Q; 2017 Dec; 88(4):787-796. PubMed ID: 28150091 [TBL] [Abstract][Full Text] [Related]
3. Clinical validation of the Aarhus Side effect Assessment Questionnaire(ASAQ). Kølbæk P; Thorgaard MV; Grooss AS; Selvanathan T; Larsen SF; Speed M; Dines D; Østergaard SD J Psychopharmacol; 2022 Apr; 36(4):507-515. PubMed ID: 35234056 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study. Graff-Guerrero A; Rajji TK; Mulsant BH; Nakajima S; Caravaggio F; Suzuki T; Uchida H; Gerretsen P; Mar W; Pollock BG; Mamo DC JAMA Psychiatry; 2015 Sep; 72(9):927-34. PubMed ID: 26131622 [TBL] [Abstract][Full Text] [Related]
5. Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication. Widschwendter CG; Kemmler G; Rettenbacher MA; Yalcin-Siedentopf N; Hofer A BMC Psychiatry; 2018 Jun; 18(1):212. PubMed ID: 29954366 [TBL] [Abstract][Full Text] [Related]
6. Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders. Rodolico A; Concerto C; Ciancio A; Siafis S; Fusar-Poli L; Romano CB; Scavo EV; Petralia A; Salomone S; Signorelli MS; Leucht S; Aguglia E Brain Sci; 2022 Jul; 12(7):. PubMed ID: 35884698 [TBL] [Abstract][Full Text] [Related]
7. Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat). Lindström E; Lewander T; Malm U; Malt UF; Lublin H; Ahlfors UG Nord J Psychiatry; 2001; 55 Suppl 44():5-69. PubMed ID: 11860666 [TBL] [Abstract][Full Text] [Related]
8. Effect of integrated yoga on anti-psychotic induced side effects and cognitive functions in patients suffering from schizophrenia. Verma M; Bhargav H; Varambally S; Raghuram N; Bn G J Complement Integr Med; 2018 Jun; 16(1):. PubMed ID: 29944467 [TBL] [Abstract][Full Text] [Related]
9. Chinese version of the Psychotropic-related Sexual Dysfunction Questionnaire (PRSexDQ -SALSEX): Validity and reliability for schizophrenic patients taking antipsychotics. Wang YX; Zhang P; Xin LM; Chen L; Liu YH; Su YA; Si TM Psychiatry Res; 2016 Dec; 246():303-307. PubMed ID: 27744232 [TBL] [Abstract][Full Text] [Related]
10. Sexual dysfunction in patients with schizophrenia and schizoaffective disorder and its association with adherence to antipsychotic medication. Souaiby L; Kazour F; Zoghbi M; Bou Khalil R; Richa S J Ment Health; 2020 Dec; 29(6):623-630. PubMed ID: 30862199 [No Abstract] [Full Text] [Related]
11. What side effects are problematic for patients prescribed antipsychotic medication? The Maudsley Side Effects (MSE) measure for antipsychotic medication. Wykes T; Evans J; Paton C; Barnes TRE; Taylor D; Bentall R; Dalton B; Ruffell T; Rose D; Vitoratou S Psychol Med; 2017 Oct; 47(13):2369-2378. PubMed ID: 28420450 [TBL] [Abstract][Full Text] [Related]
12. Side effect burden of antipsychotic drugs in real life - Impact of gender and polypharmacy. Iversen TSJ; Steen NE; Dieset I; Hope S; Mørch R; Gardsjord ES; Jørgensen KN; Melle I; Andreassen OA; Molden E; Jönsson EG Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():263-271. PubMed ID: 29122637 [TBL] [Abstract][Full Text] [Related]
13. Quality of Life and Hormonal, Biochemical, and Anthropometric Profile Between Olanzapine and Risperidone Users. de Araújo AA; Ribeiro SB; Dos Santos AC; Lemos TM; Medeiros CA; Guerra GC; de Araújo Júnior RF; Serrano-Blanco A; Rubio-Valera M Psychiatr Q; 2016 Jun; 87(2):293-304. PubMed ID: 26220635 [TBL] [Abstract][Full Text] [Related]
14. Rating scales to measure side effects of antipsychotic medication: A systematic review. van Strien AM; Keijsers CJ; Derijks HJ; van Marum RJ J Psychopharmacol; 2015 Aug; 29(8):857-66. PubMed ID: 26156860 [TBL] [Abstract][Full Text] [Related]
15. Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder. Kim JH; Choi SW; Joe SH; Ha TH; Yoo HJ; Choi JE; Cha B; Ha K Nord J Psychiatry; 2008; 62(6):496-502. PubMed ID: 18841509 [TBL] [Abstract][Full Text] [Related]
16. Clinical evolution of patients treated with aripiprazole long-acting injectable: a preliminary, prospective, observational study. García Álvarez JC; González Sánchez L; García Resa E; Bonete Llácer JM; Román Rodríguez A; Pecino Esquerdo B; Pérez Martínez E Int J Psychiatry Clin Pract; 2020 Mar; 24(1):10-17. PubMed ID: 31933402 [No Abstract] [Full Text] [Related]
17. Quality of life and adverse effects of olanzapine versus risperidone therapy in patients with schizophrenia. Chaves KM; Serrano-Blanco A; Ribeiro SB; Soares LA; Guerra GC; do Socorro Costa Feitosa Alves M; de Araújo Júnior RF; de Paula Soares Rachetti V; Filgueira Júnior A; de Araújo AA Psychiatr Q; 2013 Mar; 84(1):125-35. PubMed ID: 22806578 [TBL] [Abstract][Full Text] [Related]
18. A 12-week, naturalistic switch study of the efficacy and tolerability of aripiprazole in stable outpatients with schizophrenia or schizoaffective disorder. Kim CY; Chung S; Lee JN; Kwon JS; Kim DH; Kim CE; Jeong B; Jeon YW; Lee MS; Jun TY; Jung HY Int Clin Psychopharmacol; 2009 Jul; 24(4):181-8. PubMed ID: 19451828 [TBL] [Abstract][Full Text] [Related]
19. [Quality of life in patients with schizophrenia: a study of 100 cases]. Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268 [TBL] [Abstract][Full Text] [Related]
20. Quality of life in patients with schizophrenia: the impact of socio-economic factors and adverse effects of atypical antipsychotics drugs. de Araújo AA; de Araújo Dantas D; do Nascimento GG; Ribeiro SB; Chaves KM; de Lima Silva V; de Araújo RF; de Souza DL; de Medeiros CA Psychiatr Q; 2014 Sep; 85(3):357-67. PubMed ID: 24789610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]